{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T21:42:35Z","timestamp":1648590155725},"reference-count":55,"publisher":"Baishideng Publishing Group Inc.","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["WJGPT"],"published-print":{"date-parts":[[2015]]},"DOI":"10.4292\/wjgpt.v6.i4.96","type":"journal-article","created":{"date-parts":[[2015,11,5]],"date-time":"2015-11-05T01:28:17Z","timestamp":1446686897000},"page":"96","source":"Crossref","is-referenced-by-count":3,"title":["Present state and future challenges in pediatric abdominal pain therapeutics research: Looking beyond the forest"],"prefix":"10.4292","volume":"6","author":[{"given":"Craig A","family":"Friesen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2060","reference":[{"key":"ref1","unstructured":"U.S. Department of Health and Human Services Food and Drug Administration Available from: <ext-link ext-link-type=\"uri\" xlink:href=\"http:\/\/www.fda.gov\/downloads\/scienceresearch\/specialtopics\/personalizedmedicine\/ucm372421.pdf\" xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\">http:\/\/www.fda.gov\/downloads\/scienceresearch\/specialtopics\/personalizedmedicine\/ucm372421.pdf<\/ext-link>."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp1006304"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1093\/jpepsy\/jst140"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003017.pub2"},{"key":"ref5","unstructured":"European Medicines Agency. Guidelines on the evaluation of medicinal products for the treatment of irritable bowel syndrome (CPMP\/EWP\/785\/97) 2014. Available from: <ext-link ext-link-type=\"uri\" xlink:href=\"http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Scientific_guideline\/2014\/09\/WC500173457.pdf\" xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\">http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Scientific_guideline\/2014\/09\/WC500173457.pdf<\/ext-link>."},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.peds.2014.09.067"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"Levy RL, van Tilburg MA. Functional abdominal pain in childhood: background studies and recent research trends. Pain Res Manag 2012;17:413-417.","DOI":"10.1155\/2012\/960104"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"Yacob D, Di Lorenzo C. Functional abdominal pain: all roads lead to Rome (criteria). Pediatr Ann 2009;38:253-258.","DOI":"10.3928\/00904481-20090501-05"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"Whitfield KL, Shulman RJ. Treatment options for functional gastrointestinal disorders: from empiric to complementary approaches. Pediatr Ann 2009;38:288-290, 292-294.","DOI":"10.3928\/00904481-20090501-11"},{"key":"ref10","unstructured":"Miller LE. Study design considerations for irritable bowel syndrome clinical trials. Ann Gastroenterol 2014;27:338-345."},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"Rasquin A, Di Lorenzo C, Forbes D, Guiraldes E, Hyams JS, Staiano A, Walker LS. Childhood functional gastrointestinal disorders: child\/adolescent. Gastroenterology 2006;130:1527-1537.","DOI":"10.1053\/j.gastro.2005.08.063"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"Walker LS, Lipani TA, Greene JW, Caines K, Stutts J, Polk DB, Caplan A, Rasquin-Weber A. Recurrent abdominal pain: symptom subtypes based on the Rome II Criteria for pediatric functional gastrointestinal disorders. J Pediatr Gastroenterol Nutr 2004;38:187-191.","DOI":"10.1097\/00005176-200402000-00016"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"Schurman JV, Friesen CA, Danda CE, Andre L, Welchert E, Lavenbarg T, Cocjin JT, Hyman PE. Diagnosing functional abdominal pain with the Rome II criteria: parent, child, and clinician agreement. J Pediatr Gastroenterol Nutr 2005;41:291-295.","DOI":"10.1097\/01.mpg.0000178438.64675.c4"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1111\/nmo.12056"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2010.350"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1111\/apt.12865"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1097\/MPG.0b013e3181d1363c"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2014.01.031"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1097\/MPG.0b013e3182964203"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.5056\/jnm.2011.17.4.360"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1186\/1471-230X-11-94"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1097\/MPG.0b013e3181ae3610"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1097\/MPG.0000000000000319"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.4292\/wjgpt.v5.i3.122"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.4292\/wjgpt.v4.i4.86"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v20.i10.2456"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1007\/s10880-008-9120-0"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1016\/j.pain.2012.03.026"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1037\/cppp0000095"},{"key":"ref30","doi-asserted-by":"crossref","unstructured":"Magnusson J, Lin XP, Dahlman-H&ouml;glund A, Hanson L LA, Telemo E, Magnusson O, Bengtsson U, Ahlstedt S. Seasonal intestinal inflammation in patients with birch pollen allergy. J Allergy Clin Immunol 2003;112:45-50.","DOI":"10.1067\/mai.2003.1604"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2010-0082"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1136\/adc.82.2.177"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.2147\/PHMT.S46069"},{"key":"ref34","doi-asserted-by":"crossref","unstructured":"Wagner J, Abdel-Rahman SM. Pediatric pharmacokinetics. Pediatr Rev 2013;34:258-269.","DOI":"10.1542\/pir.34-6-258"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2007-1529"},{"key":"ref36","unstructured":"U.S. Department of Health and Human Services Food and Drug Administration Available from: <ext-link ext-link-type=\"uri\" xlink:href=\"http:\/\/www.fda.gov\/downloads\/drugs\/guidancecomplianceregulatoryinformation\/guidances\/ucm425885.pdf\" xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\">http:\/\/www.fda.gov\/downloads\/drugs\/guidancecomplianceregulatoryinformation\/guidances\/ucm425885.pdf<\/ext-link>."},{"key":"ref37","unstructured":"U.S. Department of Health and Human Services Food and Drug Administration, Center for Drug Evaluation and Research (CDER). : Guidance for industry population pharmacokinetics; ."},{"key":"ref38","doi-asserted-by":"crossref","unstructured":"Abdel-Rahman SM, Reed MD, Wells TG, Kearns GL. Considerations in the rational design and conduct of phase I\/II pediatric clinical trials: avoiding the problems and pitfalls. Clin Pharmacol Ther 2007;81:483-494.","DOI":"10.1038\/sj.clpt.6100134"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.107.104950"},{"key":"ref40","doi-asserted-by":"crossref","unstructured":"Irvine EJ, Whitehead WE, Chey WD, Matsueda K, Shaw M, Talley NJ, Veldhuyzen van Zanten SJ. Design of treatment trials for functional gastrointestinal disorders. Gastroenterology 2006;130:1538-1551.","DOI":"10.1053\/j.gastro.2005.11.058"},{"key":"ref41","unstructured":"U.S. Department of Health and Human Services Food and Drug Administration Available from: <ext-link ext-link-type=\"uri\" xlink:href=\"http:\/\/www.fda.gov\/downloads\/Drugs\/Guidances\/UCM193282.pdf\" xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\">http:\/\/www.fda.gov\/downloads\/Drugs\/Guidances\/UCM193282.pdf<\/ext-link>."},{"key":"ref42","unstructured":"U.S. Department of Health and Human Services Food and Drug Administration Available from: <ext-link ext-link-type=\"uri\" xlink:href=\"http:\/\/www.fda.gov\/downloads\/Drugs\/...\/Guidances\/UCM205269.pdf\" xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\">http:\/\/www.fda.gov\/downloads\/Drugs\/...\/Guidances\/UCM205269.pdf<\/ext-link>."},{"key":"ref43","doi-asserted-by":"crossref","unstructured":"Huertas-Ceballos A, Logan S, Bennett C, Macarthur C. Pharmacological interventions for recurrent abdominal pain (RAP) and irritable bowel syndrome (IBS) in childhood. Cochrane Database Syst Rev 2008;1:CD003017.","DOI":"10.1002\/14651858.CD003017.pub2"},{"key":"ref44","doi-asserted-by":"crossref","unstructured":"Symon DN, Russell G. Double blind placebo controlled trial of pizotifen syrup in the treatment of abdominal migraine. Arch Dis Child 1995;72:48-50.","DOI":"10.1136\/adc.72.1.48"},{"key":"ref45","doi-asserted-by":"crossref","unstructured":"Kline RM, Kline JJ, Di Palma J GJ. Enteric-coated, pH-dependent peppermint oil capsules for the treatment of irritable bowel syndrome in children. J Pediatr 2001;138:125-128.","DOI":"10.1067\/mpd.2001.109606"},{"key":"ref46","doi-asserted-by":"crossref","unstructured":"See MC, Birnbaum AH, Schechter CB, Goldenberg MM, Benkov KJ. Double-blind, placebo-controlled trial of famotidine in children with abdominal pain and dyspepsia: global and quantitative assessment. Dig Dis Sci 2001;46:985-992.","DOI":"10.1023\/A:1010793408132"},{"key":"ref47","doi-asserted-by":"crossref","unstructured":"Friesen CA, Kearns GL, Andre L, Neustrom M, Roberts CC, Abdel-Rahman SM. Clinical efficacy and pharmacokinetics of montelukast in dyspeptic children with duodenal eosinophilia. J Pediatr Gastroenterol Nutr 2004;38:343-351.","DOI":"10.1097\/00005176-200403000-00021"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds"},{"key":"ref49","unstructured":"Sadeghian M, Farahmand F, Fallahi GH, Abbasi A. Cyproheptadine for the treatment of functional abdominal pain in childhood: a double-blinded randomized placebo-controlled trial. Minerva Pediatr 2008;60:1367-1374."},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2009.06.060"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/191026"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1093\/jpepsy\/jsq010"},{"key":"ref53","doi-asserted-by":"crossref","unstructured":"Proschan MA. Sample size re-estimation in clinical trials. Biom J 2009;51:348-357.","DOI":"10.1002\/bimj.200800266"},{"key":"ref54","unstructured":"U.S. Department of Health and Human Services Food and Drug Administration Available from: <ext-link ext-link-type=\"uri\" xlink:href=\"http:\/\/www.fda.gov\/downloads\/drugs\/guidancecomplianceregulatoryinformation\/guidances\/ucm332181.pdf\" xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\">http:\/\/www.fda.gov\/downloads\/drugs\/guidancecomplianceregulatoryinformation\/guidances\/ucm332181.pdf<\/ext-link>."},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2288-12-185"}],"container-title":["World Journal of Gastrointestinal Pharmacology and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.wjgnet.com\/2150-5349\/full\/v6\/i4\/96.htm","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,10]],"date-time":"2020-09-10T23:31:16Z","timestamp":1599780676000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.wjgnet.com\/2150-5349\/full\/v6\/i4\/96.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015]]},"references-count":55,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.4292\/wjgpt.v6.i4.96","relation":{},"ISSN":["2150-5349"],"issn-type":[{"value":"2150-5349","type":"print"}],"subject":[],"published":{"date-parts":[[2015]]}}}